Medicina
Departamento
Maastricht University
Maastricht, HolandaPublicaciones en colaboración con investigadores/as de Maastricht University (27)
2024
-
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Journal of neurology, Vol. 271, Núm. 1, pp. 472-485
2023
-
Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
Psychological Assessment, Vol. 35, Núm. 2, pp. 94-114
-
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 29, Núm. 7, pp. 875-883
-
The current clinical practice for management of post-infarction ventricular septal rupture: a European survey
European Heart Journal Open, Vol. 3, Núm. 5
2022
-
Endurance Time during Constant Work Rate Cycle Ergometry in COPD: Development of an Integrated Database from Interventional Studies
Chronic Obstructive Pulmonary Diseases, Vol. 9, Núm. 4, pp. 520-537
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
2021
-
Electrocardiographic Imaging for Atrial Fibrillation: A Perspective From Computer Models and Animal Experiments to Clinical Value
Frontiers in Physiology, Vol. 12
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964
-
Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels
Alimentary Pharmacology and Therapeutics, Vol. 54, Núm. 8, pp. 999-1012
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial
Open Heart, Vol. 7, Núm. 2
-
Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population
Clinical and Translational Oncology, Vol. 22, Núm. 10, pp. 1857-1866
-
Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statement
Cardiovascular Research, Vol. 116, Núm. 1, pp. 12-27
2019
-
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2109-2119
2018
-
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
Annals of Neurology, Vol. 84, Núm. 5, pp. 729-740
2017
-
European vignettes in donation after circulatory death
Progress in Transplantation, Vol. 27, Núm. 3, pp. 286-290
2016
-
Do self-management interventions work in patients with heart failure? An individual patient data meta-analysis
Circulation, Vol. 133, Núm. 12, pp. 1189-1198
-
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)
Annals of Oncology, Vol. 27, Núm. 9, pp. 1719-1725
2015
-
ESPEN endorsed recommendations: Definition and classification of intestinal failure in adults
Clinical Nutrition, Vol. 34, Núm. 2, pp. 171-180
2014
-
The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: An analysis from the randomized ASSET study
Annals of Transplantation, Vol. 19, Núm. 1, pp. 337-345